| Literature DB >> 33810194 |
Cassandra Pouget1, Claude-Alexandre Gustave2, Christelle Ngba-Essebe1, Frédéric Laurent2,3, Emmanuel Lemichez4, Anne Tristan2,3, Albert Sotto5, Catherine Dunyach-Rémy6, Jean-Philippe Lavigne6.
Abstract
Staphylococcus aureus is the most prevalent pathogen isolated from diabetic foot infections (DFIs). The purpose of this study was to evaluate its behavior in an in vitro model mimicking the conditions encountered in DFI. Four clinical S. aureus strains were cultivated for 16 weeks in a specific environment based on the wound-like medium biofilm model. The adaptation of isolates was evaluated as follows: by Caenorhabditis elegans model (to evaluate virulence); by quantitative Reverse Transcription-Polymerase Chain Reaction (qRT-PCR) (to evaluate expression of the main virulence genes); and by Biofilm Ring test® (to assess the biofilm formation). After 16 weeks, the four S. aureus had adapted their metabolism, with the development of small colony variants and the loss of β-hemolysin expression. The in vivo nematode model suggested a decrease of virulence, confirmed by qRT-PCRs, showing a significant decrease of expression of the main staphylococcal virulence genes tested, notably the toxin-encoding genes. An increased expression of genes involved in adhesion and biofilm was noted. Our data based on an in vitro model confirm the impact of environment on the adaptation switch of S. aureus to prolonged stress environmental conditions. These results contribute to explore and characterize the virulence of S. aureus in chronic wounds.Entities:
Keywords: EDIN; Panton–Valentin leukocidin; Staphylococcus aureus; adaptation; biofilm; diabetic foot infection; in vitro model; nematode; virulence
Year: 2021 PMID: 33810194 PMCID: PMC8005162 DOI: 10.3390/toxins13030230
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
S. aureus strains used in the study.
| Strains | Characteristics | References |
|---|---|---|
|
| [ | |
|
| [ | |
|
| [ | |
|
| [ |
DFI, diabetic foot infection; DFU, diabetic foot ulcer; PVL, Panton–Valentine Leukocidin; ST, sequence type.
Phenotypical modifications of S. aureus cultivated in an in vitro wound-like medium (WLM) mimicking the conditions encountered in chronic wounds and with the addition of other stress parameters (high glucose concentration, addition of antibiotics) for 16 weeks. Bold results are statistically significant (p < 0.01) compared with WLM alone.
| Strains | In Vitro WLM Alone | WLM + | WLM + | WLM + | WLM + | WLM + | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| β-hemol 1 | SCV 2 | β-hemol | SCV | β-hemol | SCV | β-hemol | SCV | β-hemol | SCV | β-hemol | SCV | |
| NSA739 | 99% ± 2 | 2% ± 2 |
|
| 93% ± 5 | 2% ± 2 |
| 5% ± 2 |
|
|
|
|
| NSA1077 | 98% ± 3 | 2% ± 2 |
|
|
| 2% ± 3 |
|
|
|
|
|
|
| NSA7475 | 98% ± 2 | 1% ± 2 |
|
|
| 4% ± 2 |
|
|
|
|
|
|
| NSA1385 | 99% ± 2 | 0% ± 2 | 93%± 7 | 4% ± 2 | 100% ± 2 | 0% ± 2 |
|
| 94% ± 2 | 2% ± 2 | 91% ± 5 | 3% ± 3 |
1 β-hemolysis. 2 SCV, small colony variant. % corresponds to a mean of counts (±standard deviation) performed on three independent experiments on an average of 200 colonies.
50% lethal time (in days) of Caenorhabditis elegans infected by different S. aureus cultivated in an in vitro wound-like medium (WLM) mimicking the conditions encountered in chronic wounds and with the addition of stress factors (high glucose concentration, sub-minimum inhibitory concentration (MIC) of antibiotics). The results are representative of at least four independent trials for each strain.
| Strains | Length of Preculture | Without Pre-Culture in WLM | WLM Alone | WLM + 10% Glucose | WLM + | WLM + | WLM + | WLM + |
|---|---|---|---|---|---|---|---|---|
| NSA739 24 h | 24 h | 1.7 ± 0.3 | 3.5 ± 0.2 | 3.5 ± 0.3 | 3.4 ± 0.2 | 3.8 ± 0.3 | 3.9 ± 0.2 |
|
| NSA739 16-week | 16 weeks | NA | 3.9 ± 0.2 |
| 3.2 ± 0.3 |
|
|
|
| NSA1077 24 h | 24 h | 2.2 ± 0.2 | 3.9 ± 0.2 | 4.2 ± 0.3 | 4.1 ± 0.1 | 4.3 ± 0.2 | 4.4 ± 0.1 |
|
| NSA1077 16-week | 16 weeks | NA | 4.4 ± 0.1 |
| 3.7 ± 0.2 |
|
|
|
| NSA7475 24 h | 24 h | 2.3 ± 0.3 | 3.8 ± 0.2 | 3.9 ± 0.3 | 3.7 ± 0.2 | 3.5 ± 0.2 | 3.8 ± 0.2 |
|
| NSA7475 16-week | 16 weeks | NA | 4.3 ± 0.3 |
| 3.5 ± 0.2 | 4.7 ± 0.3 |
| 5.0 ± 0.2 |
| 1385 24 h | 24 h | 4.3 ± 0.3 | 4.8 ± 0.3 | 4.6 ± 0.3 | 4.3 ± 0.4 | 5.1 ± 0.2 | 4.8 ± 0.3 | 4.4 ± 0.2 |
| 1385 16-week | 16 weeks | NA | 5.0 ± 0.4 | 5.2 ± 0.2 | 5.1 ± 0.2 | 5.1 ± 0.3 | 4.9 ± 0.3 | 4.9 ± 0.2 |
| OP50 (Control strain) | - | 7.7 ± 0.2 | NA | NA | NA | NA | NA | NA |
In bold, p < 0.01 after a pairwise comparison between LT50s (strain in WLM alone vs. others) using a log rank test. NA, not applicable.
Figure 1Effects of a pre-culture in a wound-like medium (WLM) and 10% glucose combined with sub-minimum inhibitory concentration (MIC) of vancomycin (0.5× MIC) and linezolid (0.5× MIC) on S. aureus biofilm formation after 16 weeks of culture. The kinetics of the early phase of biofilm formation were determined on (A) NSA739; (B) NSA1077; (C) NSA7475; and (D) NSA1385 by the BioFilm ring test® (BioFilm Control, France). The control corresponds to the evaluation of biofilm formation of strains in Brain Heart Infusion (BHI) medium alone. Dotted horizontal lines: >7, no biofilm; <2, fixed biofilm. Means ± standard errors of the mean of biofilm indexes (BFIs) for at least three independent replicates are presented. Statistical differences between the different culture conditions at each time were obtained using two-way analysis of variance (ANOVA), followed by Dunnett’s multiple-comparison test.
Figure 2Relative mRNA expression levels of toxinogenic genes of S. aureus NSA1077 strain cultivated in WLM supplemented with 10% glucose, vancomycin (0.5× MIC), linezolid (0.5× MIC), 10% glucose + vancomycin (0.5× MIC), and 10% glucose + linezolid (0.5× MIC) after 24 h (H24) and 16 weeks (W16). The log-transformed averages of relative fold changes of NSA1077 in different environmental media compared with NSA1077 in Luria-Bertani (LB) medium for 24 h and 16 weeks are presented. The error bars represent the standard deviations from the three independent RNA preparations. Significant differences from the NSA1077 in LB medium for 24 h and 16 weeks using Dunnett’s test are indicated. *, p < 0.01; ***, p < 0.001.
Figure 3Relative mRNA expression levels of virulence genes and a regulator gene of S. aureus NSA739 strain cultivated in WLM supplemented with 10% glucose, vancomycin (0.5× MIC), linezolid (0.5× MIC), 10% glucose + vancomycin (0.5× MIC), and 10% glucose + linezolid (0.5× MIC) after a long exposure (16 weeks). The log-transformed averages of relative fold changes of NSA739 in different environmental media compared with NSA739 in LB medium are presented. The error bars represent the standard deviations from the three independent RNA preparations. Significant differences from the NSA739 in LB medium using Dunnett’s test are indicated. ***, p < 0.001.
Overview of effect of glucose and sub-MIC antibiotic concentrations on S. aureus virulence expression from an in vitro wound-like medium (WLM) mimicking the conditions encountered in chronic wounds.
| Effect on Expression of Virulence Factor 1 | ||||
|---|---|---|---|---|
| PVL | EDIN | Alpha-Hemolysin | Protein A | |
| Short exposure in WLM added to | ||||
| Glucose | ↑↑ | ↑↑ | - | ↓ |
| Vancomycin | - | - | - | - |
| Linezolid | ↑↑ | ↓ | ↓ | ↓ |
| Long exposure in WLM added to | ||||
| Glucose | ↓ | ↓ | ↓ | ↑ |
| Vancomycin | - | ↓↓ | ↑ | ↓ |
| Linezolid | ↓↓ | ↓↓ | ↓ | ↑ |
1 ↑, significant increase; ↑↑, >8-fold significant increase; ↓, significant decrease; ↓↓, >8-fold significant decrease; -, no significant effect.